Literature DB >> 10788607

Anomalous RNA substrates for mammalian tRNA 3' processing endoribonuclease.

M Nashimoto1.   

Abstract

Mammalian tRNA 3' processing endoribonuclease (3' tRNase) is an enzyme responsible for the removal of a 3' trailer from pre-tRNA. The enzyme can also recognize and cleave any target RNA that forms a pre-tRNA-like complex with another RNA. To investigate the interaction between 3' tRNase and substrates, we tested various anomalous pre-tRNA-like complexes for cleavage by pig 3' tRNase. We examined how base mismatches in the acceptor stem affect 3' tRNase cleavage of RNA complexes, and found that even one base mismatch in the acceptor stem drastically reduces the cleavage efficiency. Mammalian 3' tRNase was able to recognize complexes between target RNAs and 5'-half tDNAs, and cleave the target RNAs, although inefficiently, whereas the enzyme had no activity to cleave phosphodiester bonds of DNA. A relatively long RNA target, the Escherichia coli chloramphenicol acetyltransferase (CAT) mRNA, was cleaved by 3' tRNase in the presence of appropriate 5'-half tRNAs. We also demonstrated that an RNA complex of lin-4 and lin-14 from Caenorhabditis elegans can be recognized and cleaved by pig 3' tRNase.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10788607     DOI: 10.1016/s0014-5793(00)01462-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

1.  Intracellular mRNA cleavage by 3' tRNase under the direction of 2'-O-methyl RNA heptamers.

Authors:  Masato Tamura; Chikako Nashimoto; Noriko Miyake; Yasushi Daikuhara; Kozo Ochi; Masayuki Nashimoto
Journal:  Nucleic Acids Res       Date:  2003-08-01       Impact factor: 16.971

2.  A novel 4-base-recognizing RNA cutter that can remove the single 3' terminal nucleotides from RNA molecules.

Authors:  Hiroaki Takaku; Asako Minagawa; Masamichi Takagi; Masayuki Nashimoto
Journal:  Nucleic Acids Res       Date:  2004-06-28       Impact factor: 16.971

3.  The N-terminal half-domain of the long form of tRNase Z is required for the RNase 65 activity.

Authors:  Hiroaki Takaku; Asako Minagawa; Masamichi Takagi; Masayuki Nashimoto
Journal:  Nucleic Acids Res       Date:  2004-08-18       Impact factor: 16.971

Review 4.  3' processing of eukaryotic precursor tRNAs.

Authors:  Richard J Maraia; Tek N Lamichhane
Journal:  Wiley Interdiscip Rev RNA       Date:  2011 May-Jun       Impact factor: 9.957

5.  A candidate prostate cancer susceptibility gene encodes tRNA 3' processing endoribonuclease.

Authors:  Hiroaki Takaku; Asako Minagawa; Masamichi Takagi; Masayuki Nashimoto
Journal:  Nucleic Acids Res       Date:  2003-05-01       Impact factor: 16.971

Review 6.  TRUE Gene Silencing.

Authors:  Masayuki Nashimoto
Journal:  Int J Mol Sci       Date:  2022-05-11       Impact factor: 6.208

7.  TRUE Gene Silencing: Screening of a Heptamer-type Small Guide RNA Library for Potential Cancer Therapeutic Agents.

Authors:  Arisa Haino; Tatsuya Ishikawa; Mineaki Seki; Masayuki Nashimoto
Journal:  J Vis Exp       Date:  2016-06-02       Impact factor: 1.355

8.  Elimination of specific miRNAs by naked 14-nt sgRNAs.

Authors:  Masayuki Takahashi; Reyad A Elbarbary; Mayumi Abe; Mari Sato; Tetsuo Yoshida; Yoji Yamada; Masato Tamura; Masayuki Nashimoto
Journal:  PLoS One       Date:  2012-06-04       Impact factor: 3.240

9.  Modulation of gene expression by human cytosolic tRNase Z(L) through 5'-half-tRNA.

Authors:  Reyad A Elbarbary; Hiroaki Takaku; Naoto Uchiumi; Hiroko Tamiya; Mayumi Abe; Masayuki Takahashi; Hiroshi Nishida; Masayuki Nashimoto
Journal:  PLoS One       Date:  2009-06-15       Impact factor: 3.240

10.  Optimization and characterization of tRNA-shRNA expression constructs.

Authors:  Lisa J Scherer; Richard Frank; John J Rossi
Journal:  Nucleic Acids Res       Date:  2007-04-10       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.